Impact of robotic-assisted kidney transplantation on post-transplant infections: a case–control study

Herrera, Sabina; Carbonell, Irene; Cofan, Frederic; Cucchiari, David; Abalde, Iolanda; Bernabeu, Emilia; Sempere, Abiu; Peri, Lluís; Revuelta, Ignacio; Diekmann, Fritz; Alcaraz, Antonio; Musquera, Mireia; Bodro, Marta

doi:10.1007/s00345-023-04484-y

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The inconsistency in findings among studies may be due to variations in study populations, methodology, and most importantly age category definitions [ 25 ▪▪ ]. To sum up increasing age was confirmed as significant risk factor in six studies [ 3 ▪▪ , 11 ▪▪ , 22 ▪▪ , 23 ▪▪ , 25 ▪▪ , 28 ] comparing to three [ 24 , 29 , 30 ] studies failing to prove this association.…”

Section: Influence Of Age On Urinary Tract Infectionsmentioning

confidence: 99%

Effect of increasing age and ureteral stent implantation on urinary tract infections after kidney transplantation – update of recent literature

Omic,

Eder

2024

Current Opinion in Urology

View full text Add to dashboard Cite

Purpose of review This review aims to present the recent literature regarding effects of aging and ureteral stent implantation (UrS) on the risk of urinary tract infections (UTIs) in kidney transplant (KTX) recipients. Recent findings UTIs in kidney transplant recipients remain a clinical challenge and represent a leading cause of morbidity, hospitalization rates, and mortality. Higher age was described as a significant risk factor for UTIs in several studies including a recent Brazilian analysis, indicating a 3.6%/years of age increase in UTI risk. Subsequently, a large meta-analysis, published in 2023, confirmed the correlation between older age and elevated UTI risk. The Swiss Transplant Cohort Study in 2022, largest of its kind, similarly confirmed a link between advanced age and heightened risk of recurrent UTIs in KTX. A recent prospective study highlighted UrS placement as a modifiable risk factor, emphasizing the need for careful consideration and antibiotic prophylaxis. Additionally, the type of stents played a crucial role, with external stents associated with a 1.69 times higher UTI risk. The challenge of determining optimal UrS removal timing further complicates posttransplant care, with insufficient evidence to guide practices. Summary The aging population of KTX recipients requires a personalized approach to effectively reduce and manage UTIs as one of the most important complications following KTX. Prophylactic stent implantation is successful in lowering ureteral complications, however, is associated with an increased incidence of UTIs. To reduce the increased risk of UTIs, the length of stent insertion requires strict supervision and maintenance.

show abstract